by Cynthia McCormick Hibbert, Northeastern University Credit: Pixabay/CC0 Public DomainHuman safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall. So far the therapeutic agent, an antibiotic known as hygromycin A, has not been toxic in animals...
